Trials / Completed
CompletedNCT01427296
Safety and Efficacy of OsmoPrep® Tablets Versus HalfLytely® and Bisacodyl Tablet Bowel Prep Kit for Colon Cleansing
A Phase 4, Randomized, Active Comparator, Open-Label, Multicenter Study to Assess the Safety and Efficacy of OsmoPrep® Tablets Versus HalfLytely® and Bisacodyl Tablet Bowel Prep Kit for Colon Cleansing
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 2,154 (actual)
- Sponsor
- Bausch Health Americas, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the safety and efficacy of OsmoPrep tablets versus HalfLytely and Bisacodyl Tablet Bowel Prep Kit in subjects who are undergoing colonoscopy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Polyethylene glycol | HalfLytely and Bisacodyl Tablet Bowel Prep Kit, administered as 1 bisacodyl tablet followed by HalfLytely oral solution in a total liquid volume of approximately 2 L |
| DRUG | Oral sodium phosphate solution | OsmoPrep tablets (48 g), administered as 32 total tablets in a total liquid volume of approximately 2 L |
Timeline
- Start date
- 2011-09-16
- Primary completion
- 2014-03-11
- Completion
- 2014-12-09
- First posted
- 2011-09-01
- Last updated
- 2018-01-18
- Results posted
- 2018-01-18
Locations
18 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01427296. Inclusion in this directory is not an endorsement.